C-reactive protein-triglyceride glucose index in predicting three-vessel coronary artery disease risk: a

Ling Hou1,2,3, Yuanhong Li1, Qianfei Liu4,5

  • 1Cardiovascular Disease Center, Central Hospital of Tujia and Miao Autonomous Prefecture, Enshi, Hubei Province, People's Republic of China.

Annals of Medicine
|November 17, 2025
PubMed

Insights

The C-reactive protein-triglyceride glucose index (CTI) effectively predicts three-vessel coronary artery disease (TVD). Elevated CTI is a significant risk factor, valuable for improving patient assessment and stratification in clinical practice.

Area of Science:

  • Cardiovascular Medicine
  • Biomarker Discovery
  • Metabolic Syndrome Research

Background:

  • Three-vessel coronary artery disease (TVD) is a severe form of coronary heart disease linked to inflammation and metabolic issues.
  • The C-reactive protein-triglyceride glucose index (CTI) combines inflammation and metabolism markers, suggesting potential as a TVD predictor.

Purpose of the Study:

  • To evaluate the predictive capability of the CTI for identifying three-vessel coronary artery disease (TVD).
  • To assess the role of CTI in risk stratification for TVD patients.

Main Methods:

  • A retrospective study comparing TVD and non-TVD groups on clinical and laboratory markers.
  • Utilized Boruta algorithm and LASSO regression for feature selection and risk model construction.
  • Employed SHAP analysis for model interpretability and subgroup analyses by sex and diabetes status.

Main Results:

  • The CTI index was significantly elevated in the TVD group and identified as a key predictor alongside age and gender.
  • SHAP analysis confirmed CTI's prominent role in TVD risk assessment.
  • CTI showed a stable predictive effect across subgroups of men and diabetic patients.

Conclusions:

  • The CTI is a reliable predictor for TVD, offering immediate value for risk assessment and patient stratification.
  • CTI shows promise for future applications in early screening and long-term management of TVD.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
857
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
374
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
577
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
522
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301